Reducing hip fracture risk with risedronate in elderly women with established osteoporosis

BACKGROUND: There is limited evidence to support the efficacy of current pharmaceutical agents in reducing the risk of hip fracture in older postmenopausal women with established osteoporosis. OBJECTIVE: To clarify the efficacy of risedronate in reducing the risk of hip fracture in elderly postmenop...

Descripción completa

Detalles Bibliográficos
Autores principales: Masud, Tahir, McClung, Michael, Geusens, Piet
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785868/
https://www.ncbi.nlm.nih.gov/pubmed/19966913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785868/
https://www.ncbi.nlm.nih.gov/pubmed/19966913

Ejemplares similares